Internal Medicine - Issue Suppl 3/2015
Leaders
Editorials
8
Reviews
Original Contributions
14
The mortality of patients with diabetes mellitus using oral antidiabetic drugs in the Czech Republic decreased over the decade of 2003–2013 and came closer to the population average
Jan Brož, Petr Honěk, Ladislav Dušek, Tomáš Pavlík, Milan Kvapil
21
Incidence of amputations among patients with diabetes mellitus in the Czech Republic from 2010 to 2014
Pavlína Piťhová, Petr Honěk, Ladislav Dušek, Tomáš Pavlík, Milan Kvapil
25
Analysis of the development of metformin and sulfonylurea prescriptions in the Czech Republic
Denisa Janíčková-Žďárská, Petr Honěk, Ladislav Dušek, Tomáš Pavlík, Milan Kvapil
30
Hypolipidemic and antihypertensive therapy in diabetic patients in the Czech Republic: notes on the VZP (General Health Insurance Company) Data
Michaela Šnejdrlová, Richard Češka, Denisa Janíčková-Žďárská, Petr Honěk, Pavel Dušek, Tomáš Pavlík, Milan Kvapil
39
Monitoring of diabetes compensation in patients treated with an insulin pump in the Czech Republic
Zdeněk Rušavý, Petr Honěk, Ladislav Dušek, Tomáš Pavlík, Denisa Janíčková-Žďárská, Milan Kvapil
44
The PROROK project results after 6 months of intervention (Prospective observation project focusing on the relevance of the difference between fasting blood glucose levels and postprandial blood glucose for estimation of success of type 2 diabetes therapy)
Denisa Janíčková-Žďárská, Pavlína Piťhová, Tomáš Pavlík, Milan Kvapil
50
Clinical and economic benefits of the new antidiabetic drugs in the Czech Republic
Tomáš Doležal, Klára Kruntorádová
Internal Medicine
2015 Issue Suppl 3
Most read in this issue
- Incidence of amputations among patients with diabetes mellitus in the Czech Republic from 2010 to 2014
- The mortality of patients with diabetes mellitus using oral antidiabetic drugs in the Czech Republic decreased over the decade of 2003–2013 and came closer to the population average
- Monitoring of diabetes compensation in patients treated with an insulin pump in the Czech Republic
- Clinical and economic benefits of the new antidiabetic drugs in the Czech Republic